Philips voluntarily suspends manufacturing at an Ohio facility after an FDA investigation turns up “certain issues in the general area of manufacturing process controls.” Philips Healthcare (NYSE:PHG) halted work at an Ohio manufacturing facility after an FDA inspection turned up some concerns with process controls, a company spokesman confirmed with MassDevice.com today. “Philips announced a voluntary, temporary suspension of production at the Cleveland facility, primarily to upgrade manufacturing process controls in order to resume production as soon as possible,”
Help employers find you! Check out all the jobs and post your resume.
